DK1504036T3 - Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitet - Google Patents
Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitetInfo
- Publication number
- DK1504036T3 DK1504036T3 DK03727860.3T DK03727860T DK1504036T3 DK 1504036 T3 DK1504036 T3 DK 1504036T3 DK 03727860 T DK03727860 T DK 03727860T DK 1504036 T3 DK1504036 T3 DK 1504036T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibodies
- antiviral activity
- toxin
- antimicrobial
- microbicidal
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title abstract 2
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000003053 toxin Substances 0.000 title 1
- 231100000765 toxin Toxicity 0.000 title 1
- 230000003641 microbiacidal effect Effects 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000008574 D-amino acids Chemical class 0.000 abstract 1
- 108010022954 Yeast Killer Factors Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000816 peptidomimetic Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 239000003122 yeast killer factor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210783.7A GB0210783D0 (en) | 2002-05-10 | 2002-05-10 | Anti-microbial polypeptides |
| PCT/IB2003/002348 WO2003095493A2 (en) | 2002-05-10 | 2003-05-09 | Toxin-related antibodies with antimicrobial and antiviral activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1504036T3 true DK1504036T3 (da) | 2011-10-24 |
Family
ID=9936462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03727860.3T DK1504036T3 (da) | 2002-05-10 | 2003-05-09 | Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitet |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7722876B2 (da) |
| EP (1) | EP1504036B1 (da) |
| JP (1) | JP4405912B2 (da) |
| AT (1) | ATE514716T1 (da) |
| AU (1) | AU2003233108A1 (da) |
| BR (1) | BR0309921A (da) |
| CA (1) | CA2484704A1 (da) |
| CO (1) | CO7220324A2 (da) |
| DK (1) | DK1504036T3 (da) |
| GB (1) | GB0210783D0 (da) |
| NZ (1) | NZ536957A (da) |
| WO (1) | WO2003095493A2 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2006093071A1 (ja) * | 2005-02-28 | 2008-08-07 | 株式会社ジーンケア研究所 | βグルカン合成酵素を有する真菌に対して抗真菌活性を有する抗イディオタイプ抗体、およびその利用 |
| CA2744043A1 (en) | 2008-11-25 | 2010-06-03 | Biogen Idec Ma Inc. | Use of dr6 and p75 antagonists to promote survival of cells of the nervous system |
| WO2011060393A1 (en) * | 2009-11-16 | 2011-05-19 | Rasna Therapeutics | Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore |
| PT2663579T (pt) | 2011-01-14 | 2017-07-28 | Univ California | Terapêutica de anticorpos contra a proteína r0r-1 e métodos para sua utilização |
| EA036047B1 (ru) | 2011-07-11 | 2020-09-18 | Икнос Сайенсиз Са | Антитела, которые связываются с ox40, и их применение |
| WO2020257625A1 (en) * | 2019-06-21 | 2020-12-24 | Rowley Paul A | Compositions and methods for inhibiting yeast infections |
| US20220111018A1 (en) * | 2020-06-19 | 2022-04-14 | University Of Idaho | Compositions and methods for inhibiting yeast infections |
| CN111848740B (zh) * | 2020-08-04 | 2023-03-24 | 南京市妇幼保健院 | 一种阴道分泌源性多肽及其在抑制白色念珠菌感染中的应用 |
| EP4147716A1 (en) * | 2021-09-10 | 2023-03-15 | Samatva Research Corporation | Anti-virus moiety immobilised in a matrix |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU669379B2 (en) * | 1992-09-07 | 1996-06-06 | Kyowa Hakko Kirin Co., Ltd. | Humanized antibodies |
| WO1998008090A1 (en) * | 1995-06-06 | 1998-02-26 | Epigen, Inc. | Anti-idiotypic antibodies to an epiglycanin |
| KR100259828B1 (ko) * | 1995-09-11 | 2000-06-15 | 히라타 다다시 | 인체 인터루킨 5 수용체 알파-사슬에 대한 항체 |
| DE69737188T2 (de) * | 1996-05-04 | 2007-10-11 | Astrazeneca Ab | Monoklonaler antikoerper gegen cea, konjugate die dieses antikoerper enthalten und deren therapeutische verwendung in einem adept-system |
| ATE512225T1 (de) * | 1998-04-03 | 2011-06-15 | Chugai Pharmaceutical Co Ltd | Humanisierter antikörper gegen den menschlichen gewebefaktor (tf) und verfahren für die konstruktion eines solchen humanisierten antikörpers. |
| JP2002529705A (ja) | 1998-10-29 | 2002-09-10 | コンネクス・ゲーエムベーハー | 糞便中の耐酸性微生物を検出するための新規方法 |
| CZ20012925A3 (cs) | 1999-02-12 | 2002-01-16 | Genetics Institute, Inc. | Humanizovaný imunoglobulin reaktivní s B7 molekulami a způsob léčení |
| AU5250200A (en) * | 1999-06-17 | 2001-01-09 | Kyowa Hakko Kogyo Co. Ltd. | Diagnostics and remedies for diseases with participation of macrocytes/macrophages |
| US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
| EP1130032A1 (en) * | 2000-02-28 | 2001-09-05 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR) |
| DE10019967A1 (de) * | 2000-04-20 | 2001-10-25 | Fenning Biomed Gmbh Dr | Antikörper gegen natives gp96, deren Herstellung und Verwendung |
| AU2001271422B2 (en) * | 2000-06-22 | 2005-12-22 | Genentech, Inc. | Agonist anti-trk-C monoclonal antibodies |
-
2002
- 2002-05-10 GB GBGB0210783.7A patent/GB0210783D0/en not_active Ceased
-
2003
- 2003-05-09 DK DK03727860.3T patent/DK1504036T3/da active
- 2003-05-09 CA CA002484704A patent/CA2484704A1/en not_active Abandoned
- 2003-05-09 US US10/514,781 patent/US7722876B2/en not_active Expired - Fee Related
- 2003-05-09 JP JP2004503507A patent/JP4405912B2/ja not_active Expired - Fee Related
- 2003-05-09 EP EP03727860A patent/EP1504036B1/en not_active Expired - Lifetime
- 2003-05-09 WO PCT/IB2003/002348 patent/WO2003095493A2/en active Application Filing
- 2003-05-09 BR BR0309921-0A patent/BR0309921A/pt not_active Application Discontinuation
- 2003-05-09 AT AT03727860T patent/ATE514716T1/de not_active IP Right Cessation
- 2003-05-09 AU AU2003233108A patent/AU2003233108A1/en not_active Abandoned
- 2003-05-09 NZ NZ536957A patent/NZ536957A/en unknown
-
2004
- 2004-12-10 CO CO04124128A patent/CO7220324A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003095493A2 (en) | 2003-11-20 |
| EP1504036A2 (en) | 2005-02-09 |
| NZ536957A (en) | 2006-07-28 |
| US20060280750A1 (en) | 2006-12-14 |
| AU2003233108A1 (en) | 2003-11-11 |
| US7722876B2 (en) | 2010-05-25 |
| CO7220324A2 (es) | 2015-03-20 |
| EP1504036B1 (en) | 2011-06-29 |
| GB0210783D0 (en) | 2002-06-19 |
| BR0309921A (pt) | 2005-02-09 |
| JP4405912B2 (ja) | 2010-01-27 |
| WO2003095493A3 (en) | 2004-06-03 |
| ATE514716T1 (de) | 2011-07-15 |
| JP2006506959A (ja) | 2006-03-02 |
| CA2484704A1 (en) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100447A1 (ru) | Гибридные белки на основе бета-интерферона и их применение | |
| ATE399177T1 (de) | Derivate therapeutischer peptide | |
| DK1025124T3 (da) | Human interferon-alfa-analoge med lav toksicitet | |
| DE69838143D1 (de) | Antimikrobielle peptide | |
| DE60235761D1 (de) | Isoform des vegfs | |
| DK1017715T3 (da) | Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse | |
| DK1504036T3 (da) | Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitet | |
| NO940299L (no) | Peptid med organbeskyttende aktivitet | |
| GB9606040D0 (en) | Active peptide | |
| BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
| ATE323722T1 (de) | Antimikrobiell wirkendes peptid | |
| DE68917837D1 (de) | Peptid-Verbindungen. | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| DE60044945D1 (de) | Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür | |
| ATE385805T1 (de) | Neue peptide | |
| ATE245168T1 (de) | Peptide, die anti-zellanhaftungsaktivität aufweisen | |
| HUP9900789A2 (hu) | Lefelé irányuló szabályozásra rezisztens C3 konvertáz | |
| DE60236330D1 (de) | Biologisch aktive Peptide | |
| ATE441713T1 (de) | Tumorantigenprotein und dessen verwendung | |
| IT1271074B (it) | Peptidi ad attivita' antiinfiammatoria | |
| DK1425295T3 (da) | Modificerede peptider og deres anvendelse til behandling af autoimmune sygdomme | |
| SE9700301D0 (sv) | New compound | |
| SG170757A1 (en) | Polypeptide having esterase activity and recombinant esterase and use thereof | |
| AU4956901A (en) | Novel human 7tm proteins and polynucleotides encoding the same | |
| WO1999060117A3 (fr) | Polypeptide prax-1 |